Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions

Journal of Hepatology

Volumn 61, Issue 6, 2014, Pages 1397-1406

  Wilson, Garrick K ^a   Tennant, Daniel A ^a   McKeating, Jane A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

HIF; Hypoxia; Inflammation; Liver; Viral hepatitis

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; OXYGEN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1;

CELL METABOLISM; CELL SURVIVAL; DISEASE ASSOCIATION; DISEASE COURSE; FATTY LIVER; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER ISCHEMIA; NEGATIVE FEEDBACK; NONHUMAN; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR MICROENVIRONMENT; VIRUS HEPATITIS; ANIMAL; CARCINOMA, HEPATOCELLULAR; DISEASE MODEL; HEPATOVIRUS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS INFECTION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; HEPATOVIRUS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MICE; OXYGEN; VIRUS DISEASES;

EID: 84922744991     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.025     Document Type: Review

References (137)

1. A. Carreau, B. El Hafny-Rahbi, A. Matejuk, C. Grillon, and C. Kieda Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia J Cell Mol Med 15 2011 1239 1253
2. A.M. Rappaport The structural and functional unit in the human liver (liver acinus) Anat Rec 130 1958 673 689
3. K. Jungermann, and T. Kietzmann Oxygen: modulator of metabolic zonation and disease of the liver Hepatology 31 2000 255 260
4. R. Gebhardt, A. Baldysiak-Figiel, V. Krugel, E. Ueberham, and F. Gaunitz Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver Prog Histochem Cytochem 41 2007 201 266
5. A. Braeuning, C. Ittrich, C. Kohle, S. Hailfinger, M. Bonin, and A. Buchmann Differential gene expression in periportal and perivenous mouse hepatocytes FEBS J 273 2006 5051 5061
6. K. Jungermann, and T. Kietzmann Zonation of parenchymal and nonparenchymal metabolism in liver Annu Rev Nutr 16 1996 179 203
7. K. Jungermann, and R.G. Thurman Hepatocyte heterogeneity in the metabolism of carbohydrates Enzyme 46 1992 33 58
8. G.E. Arteel, Y. Iimuro, M. Yin, J.A. Raleigh, and R.G. Thurman Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo Hepatology 25 1997 920 926
9. B. Nath, I. Levin, T. Csak, J. Petrasek, C. Mueller, and K. Kodys Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice Hepatology 53 2011 1526 1537
10. M. Nasimuzzaman, G. Waris, D. Mikolon, D.G. Stupack, and A. Siddiqui Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor J Virol 81 2007 10249 10257
11. A. Qu, M. Taylor, X. Xue, T. Matsubara, D. Metzger, and P. Chambon Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis Hepatology 54 2011 472 483
12. G.K. Wilson, C.L. Brimacombe, I.A. Rowe, G.M. Reynolds, N.F. Fletcher, and Z. Stamataki A dual role for hypoxia inducible factor-1alpha in the hepatitis C virus lifecycle and hepatoma migration J Hepatol 56 2012 803 809
13. N. Goda, and M. Kanai Hypoxia-inducible factors and their roles in energy metabolism Int J Hematol 95 2012 457 463
14. G.L. Semenza Life with oxygen Science 318 2007 62 64
15. G.L. Wang, B.H. Jiang, E.A. Rue, and G.L. Semenza Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc Natl Acad Sci U S A 92 1995 5510 5514
16. I. Flamme, T. Frohlich, M. von Reutern, A. Kappel, A. Damert, and W. Risau HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels Mech Dev 63 1997 51 60
17. E. Berra, E. Benizri, A. Ginouves, V. Volmat, D. Roux, and J. Pouyssegur HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia EMBO J 22 2003 4082 4090
18. C.J. Schofield, and P.J. Ratcliffe Oxygen sensing by HIF hydroxylases Nat Rev Mol Cell Biol 5 2004 343 354
19. A. Ginouves, K. Ilc, N. Macias, J. Pouyssegur, and E. Berra PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis Proc Natl Acad Sci U S A 105 2008 4745 4750
20. T. Lofstedt, E. Fredlund, L. Holmquist-Mengelbier, A. Pietras, M. Ovenberger, and L. Poellinger Hypoxia inducible factor-2alpha in cancer Cell Cycle 6 2007 919 926
21. D. Lando, D.J. Peet, D.A. Whelan, J.J. Gorman, and M.L. Whitelaw Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch Science 295 2002 858 861
22. P. Koivunen, M. Hirsila, V. Gunzler, K.I. Kivirikko, and J. Myllyharju Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases J Biol Chem 279 2004 9899 9904
23. M. Hirsila, P. Koivunen, V. Gunzler, K.I. Kivirikko, and J. Myllyharju Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor J Biol Chem 278 2003 30772 30780
24. F. Dayan, D. Roux, M.C. Brahimi-Horn, J. Pouyssegur, and N.M. Mazure The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha Cancer Res 66 2006 3688 3698
25. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
26. F. Agani, and B.H. Jiang Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer Curr Cancer Drug Targets 13 2013 245 251
27. R.D. Guzy, B. Hoyos, E. Robin, H. Chen, L. Liu, and K.D. Mansfield Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing Cell Metab 1 2005 401 408
28. N.S. Chandel, D.S. McClintock, C.E. Feliciano, T.M. Wood, J.A. Melendez, and A.M. Rodriguez Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing J Biol Chem 275 2000 25130 25138
29. A. King, M.A. Selak, and E. Gottlieb Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer Oncogene 25 2006 4675 4682
30. K.X. Knaup, K. Jozefowski, R. Schmidt, W.M. Bernhardt, A. Weidemann, and J.S. Juergensen Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability Mol Cancer Res 7 2009 88 98
31. N. Sang, D.P. Stiehl, J. Bohensky, I. Leshchinsky, V. Srinivas, and J. Caro MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300 J Biol Chem 278 2003 14013 14019
32. L. Tacchini, L. Radice, and A. Bernelli-Zazzera Differential activation of some transcription factors during rat liver ischemia, reperfusion, and heat shock J Cell Physiol 180 1999 255 262
33. T.K. Howard, G.B. Klintmalm, J.B. Cofer, B.S. Husberg, R.M. Goldstein, and T.A. Gonwa The influence of preservation injury on rejection in the hepatic transplant recipient Transplantation 49 1990 103 107
34. J.J. Lemasters, S. Ji, and R.G. Thurman Centrilobular injury following hypoxia in isolated, perfused rat liver Science 213 1981 661 663
35. J.Y. Guo, T. Yang, X.G. Sun, N.Y. Zhou, F.S. Li, and D. Long Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway J Biomed Sci 18 2011 79
36. M. Schneider, K. Van Geyte, P. Fraisl, J. Kiss, J. Aragones, and M. Mazzone Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury Gastroenterology 138 2010 e1141 e1142
37. Z. Zhong, V.K. Ramshesh, H. Rehman, R.T. Currin, V. Sridharan, and T.P. Theruvath Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion Am J Physiol Gastrointest Liver Physiol 295 2008 G823 G832
38. E. Alchera, L. Tacchini, C. Imarisio, C. Dal Ponte, C. De Ponti, and E. Gammella Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells Hepatology 48 2008 230 239
39. J.K. Dowman, J.W. Tomlinson, and P.N. Newsome Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Aliment Pharmacol Ther 33 2011 525 540
40. J.K. Reddy, and M.S. Rao Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation Am J Physiol Gastrointest Liver Physiol 290 2006 G852 G858
41. F. Bardag-Gorce, B.A. French, J. Li, N.E. Riley, Q.X. Yuan, and V. Valinluck The importance of cycling of blood alcohol levels in the pathogenesis of experimental alcoholic liver disease in rats Gastroenterology 123 2002 325 335
42. S.W. French The role of hypoxia in the pathogenesis of alcoholic liver disease Hepatol Res 29 2004 69 74
43. M. Guzman, and J. Castro Zonation of fatty acid metabolism in rat liver Biochem J 264 1989 107 113
44. E.D. Bruder, P.C. Lee, and H. Raff Lipid and fatty acid profiles in the brain, liver, and stomach contents of neonatal rats: effects of hypoxia Am J Physiol Endocrinol Metab 288 2005 E314 E320
45. V.H. Haase, J.N. Glickman, M. Socolovsky, and R. Jaenisch Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor Proc Natl Acad Sci U S A 98 2001 1583 1588
46. Y. Nishiyama, N. Goda, M. Kanai, D. Niwa, K. Osanai, and Y. Yamamoto HIF-1alpha induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice J Hepatol 56 2012 441 447
47. M. Scortegagna, K. Ding, Y. Oktay, A. Gaur, F. Thurmond, and L.J. Yan Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice Nat Genet 35 2003 331 340
48. W.Y. Kim, M. Safran, M.R. Buckley, B.L. Ebert, J. Glickman, and M. Bosenberg Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo EMBO J 25 2006 4650 4662
49. E.B. Rankin, J. Rha, M.A. Selak, T.L. Unger, B. Keith, and Q.D. Liu Hypoxia-inducible factor 2 regulates hepatic lipid metabolism Mol Cell Biol 29 2009 4527 4538
50. C.M. Taniguchi, E.C. Finger, A.J. Krieg, C. Wu, A.N. Diep, and E.L. Lagory Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes Nat Med 19 2013 1325 1330
51. K. Wei, S.M. Piecewicz, L.M. McGinnis, C.M. Taniguchi, S.J. Wiegand, and K. Anderson A liver Hif-2alpha-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition Nat Med 19 2013 1331 1337
52. M.C. Bosco, M. Puppo, F. Blengio, T. Fraone, P. Cappello, and M. Giovarelli Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration Immunobiology 213 2008 733 749
53. S.Y. Kim, Y.J. Choi, S.M. Joung, B.H. Lee, Y.S. Jung, and J.Y. Lee Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor Immunology 129 2010 516 524
54. B. Acosta-Iborra, A. Elorza, I.M. Olazabal, N.B. Martin-Cofreces, S. Martin-Puig, and M. Miro Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor J Immunol 182 2009 3155 3164
55. T. Bhandari, J. Olson, R.S. Johnson, and V. Nizet HIF-1alpha influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination J Mol Med 91 2013 1199 1205
56. R. Wobben, Y. Husecken, C. Lodewick, K. Gibbert, J. Fandrey, and S. Winning Role of hypoxia inducible factor-1alpha for interferon synthesis in mouse dendritic cells Biol Chem 394 2013 495 505
57. A. Larbi, H. Zelba, D. Goldeck, and G. Pawelec Induction of HIF-1alpha and the glycolytic pathway alters apoptotic and differentiation profiles of activated human T cells J Leukoc Biol 87 2010 265 273
58. E.T. Clambey, E.N. McNamee, J.A. Westrich, L.E. Glover, E.L. Campbell, and P. Jedlicka Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa Proc Natl Acad Sci U S A 109 2012 E2784 E2793
59. J. Ben-Shoshan, S. Maysel-Auslender, A. Mor, G. Keren, and J. George Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha Eur J Immunol 38 2008 2412 2418
60. B. Langhans, B. Kramer, M. Louis, H.D. Nischalke, R. Huneburg, and A. Staratschek-Jox Intrahepatic IL-8 producing Foxp3(+)CD4(+) regulatory T cells and fibrogenesis in chronic hepatitis C J Hepatol 59 2013 229 235
61. D. Franceschini, M. Paroli, V. Francavilla, M. Videtta, S. Morrone, and G. Labbadia PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV J Clin Invest 119 2009 551 564
62. T. Manigold, and V. Racanelli T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies Lancet Infect Dis 7 2007 804 813
63. M. Pinzani Liver fibrosis Springer Semin Immunopathol 21 1999 475 490
64. B.L. Copple, S. Bai, L.D. Burgoon, and J.O. Moon Hypoxia-inducible factor-1alpha regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis Liver Int 31 2011 230 244
65. B.L. Copple, J.J. Bustamante, T.P. Welch, N.D. Kim, and J.O. Moon Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes Liver Int 29 2009 1010 1021
66. J.O. Moon, T.P. Welch, F.J. Gonzalez, and B.L. Copple Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice Am J Physiol Gastrointest Liver Physiol 296 2009 G582 G592
67. R. Bataller, and D.A. Brenner Liver fibrosis J Clin Invest 115 2005 209 218
68. E. Liaskou, H.W. Zimmermann, K.K. Li, Y.H. Oo, S. Suresh, and Z. Stamataki Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics Hepatology 57 2013 385 398
69. T.G. Bird, W.Y. Lu, L. Boulter, S. Gordon-Keylock, R.A. Ridgway, and M.J. Williams Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling Proc Natl Acad Sci U S A 110 2013 6542 6547
70. B.L. Copple, S. Kaska, and C. Wentling Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice J Pharmacol Exp Ther 341 2012 307 316
71. B. Rehermann Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Nat Med 19 2013 859 868
72. S.A. Ng, and C. Lee Hepatitis B virus X gene and hepatocarcinogenesis J Gastroenterol 46 2011 974 990
73. Y.G. Yoo, S.H. Oh, E.S. Park, H. Cho, N. Lee, and H. Park Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway J Biol Chem 278 2003 39076 39084
74. S.W. Lee, Y.M. Lee, S.K. Bae, S. Murakami, Y. Yun, and K.W. Kim Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis Biochem Biophys Res Commun 268 2000 456 461
75. Y.G. Yoo, T.Y. Na, H.W. Seo, J.K. Seong, C.K. Park, and Y.K. Shin Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells Oncogene 27 2008 3405 3413
76. L.P. Liu, B.G. Hu, C. Ye, R.L. Ho, G.G. Chen, and P.B. Lai HBx mutants differentially affect the activation of hypoxia-inducible factor-1alpha in hepatocellular carcinoma Br J Cancer 110 2013 1066 1073
77. M. Hassan, D. Selimovic, H. Ghozlan, and O. Abdel-kader Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways Hepatology 49 2009 1469 1482
78. M. Ripoli, A. D'Aprile, G. Quarato, M. Sarasin-Filipowicz, J. Gouttenoire, and R. Scrima Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation J Virol 84 2010 647 660
79. N. Vassilaki, K.I. Kalliampakou, I. Kotta-Loizou, C. Befani, P. Liakos, and G. Simos Low oxygen tension enhances hepatitis C virus replication J Virol 87 2013 2935 2948
80. C.J. Mee, M.J. Farquhar, H.J. Harris, K. Hu, W. Ramma, and A. Ahmed Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner Gastroenterology 138 2010 1134 1142
81. C.J. Mee, H.J. Harris, M.J. Farquhar, G. Wilson, G. Reynolds, and C. Davis Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells J Virol 83 2009 6211 6221
82. J. Munger, S.U. Bajad, H.A. Coller, T. Shenk, and J.D. Rabinowitz Dynamics of the cellular metabolome during human cytomegalovirus infection PLoS Pathog 2 2006 e132
83. E.Y. Chan, W.J. Qian, D.L. Diamond, T. Liu, M.A. Gritsenko, and M.E. Monroe Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production J Virol 81 2007 7571 7583
84. D.L. Diamond, A.J. Syder, J.M. Jacobs, C.M. Sorensen, K.A. Walters, and S.C. Proll Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics PLoS Pathog 6 2010 e1000719
85. H.B. El-Serag Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 2012 e1261
86. C.C. Wong, A.K. Kai, and I.O. Ng The impact of hypoxia in hepatocellular carcinoma metastasis Front Med 8 2013 33 41
87. Q. Zhang, X. Bai, W. Chen, T. Ma, Q. Hu, and C. Liang Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling Carcinogenesis 34 2013 962 973
88. C.X. Dai, Q. Gao, S.J. Qiu, M.J. Ju, M.Y. Cai, and Y.F. Xu Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery BMC Cancer 9 2009 418
89. Z.L. Xiang, Z.C. Zeng, J. Fan, Z.Y. Tang, H.Y. Zeng, and D.M. Gao Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1alpha, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma Clin Cancer Res 17 2011 5463 5472
90. S.S. Zheng, X.H. Chen, X. Yin, and B.H. Zhang Prognostic significance of HIF-1alpha expression in hepatocellular carcinoma: a meta-analysis PLoS One 8 2013 e65753
91. G.Y. Gwak, J.H. Yoon, K.M. Kim, H.S. Lee, J.W. Chung, and G.J. Gores Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression J Hepatol 42 2005 358 364
92. W. Kim, J.H. Yoon, J.M. Jeong, G.J. Cheon, T.S. Lee, and J.I. Yang Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma Mol Cancer Ther 6 2007 2554 2562
93. S.L. Sheng, J.J. Liu, Y.H. Dai, X.G. Sun, X.P. Xiong, and G. Huang Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma FEBS J 279 2012 3898 3910
94. D.A. Tennant, R.V. Duran, H. Boulahbel, and E. Gottlieb Metabolic transformation in cancer Carcinogenesis 30 2009 1269 1280
95. R. Ma, W. Zhang, K. Tang, H. Zhang, Y. Zhang, and D. Li Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma Nat Commun 4 2013 2508
96. K. Wei, S.M. Piecewicz, L.M. McGinnis, C.M. Taniguchi, S.J. Wiegand, and K. Anderson A liver Hif-2alpha-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition Nat Med 19 2013 1331 1337
97. H.X. Sun, Y. Xu, X.R. Yang, W.M. Wang, H. Bai, and R.Y. Shi Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/E2F transcription factor 1-dependent apoptotic pathway Hepatology 57 2013 1088 1097
98. V. Hernandez-Gea, S. Toffanin, S.L. Friedman, and J.M. Llovet Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma Gastroenterology 144 2013 512 527
99. D.W. McMillin, J. Delmore, E. Weisberg, J.M. Negri, D.C. Geer, and S. Klippel Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity Nat Med 16 2010 483 489
100. C.S. Mitsiades, N. Mitsiades, N.C. Munshi, and K.C. Anderson Focus on multiple myeloma Cancer Cell 6 2004 439 444
101. K.P. Olive, M.A. Jacobetz, C.J. Davidson, A. Gopinathan, D. McIntyre, and D. Honess Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 2009 1457 1461
102. A. Casazza, G. Di Conza, M. Wenes, V. Finisguerra, S. Deschoemaeker, and M. Mazzone Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment Oncogene 33 2014 1743 1754
103. Z.Y. Lin, Y.H. Chuang, and W.L. Chuang Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6, and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells Biomed Pharmacother 66 2012 525 529
104. A. Mazzocca, F. Dituri, L. Lupo, M. Quaranta, S. Antonaci, and G. Giannelli Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts Hepatology 54 2011 920 930
105. C. Rancoule, M. Viaud, S. Gres, N. Viguerie, P. Decaunes, and A. Bouloumie Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence Biochim Biophys Acta 1841 2014 88 96
106. S.J. Lee, Y.R. No, D.T. Dang, L.H. Dang, V.W. Yang, and H. Shim Regulation of hypoxia-inducible factor 1alpha (HIF-1alpha) by lysophosphatidic acid is dependent on interplay between p53 and Kruppel-like factor 5 J Biol Chem 288 2013 25244 25253
107. P.Y. Wu, Y.C. Lin, S.Y. Lan, Y.L. Huang, and H. Lee Aromatic hydrocarbon receptor inhibits lysophosphatidic acid-induced vascular endothelial growth factor-A expression in PC-3 prostate cancer cells Biochem Biophys Res Commun 437 2013 440 445
108. D. Lukashev, B. Klebanov, H. Kojima, A. Grinberg, A. Ohta, and L. Berenfeld Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes J Immunol 177 2006 4962 4965
109. A. Palazon, J. Aragones, A. Morales-Kastresana, M.O. de Landazuri, and I. Melero Molecular pathways: hypoxia response in immune cells fighting or promoting cancer Clin Cancer Res 18 2012 1207 1213
110. M.Z. Noman, G. Desantis, B. Janji, M. Hasmim, S. Karray, and P. Dessen PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation J Exp Med 211 2014 781 790
111. A.L. Doedens, A.T. Phan, M.H. Stradner, J.K. Fujimoto, J.V. Nguyen, and E. Yang Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen Nat Immunol 14 2013 1173 1182
112. H.Z. Imtiyaz, and M.C. Simon Hypoxia-inducible factors as essential regulators of inflammation Curr Top Microbiol Immunol 345 2010 105 120
113. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
114. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
115. A.L. Cheng, Y.K. Kang, D.Y. Lin, J.W. Park, M. Kudo, and S. Qin Sunitinib vs. sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial J Clin Oncol 31 2013 4067 4075
116. M. Kioi, H. Vogel, G. Schultz, R.M. Hoffman, G.R. Harsh, and J.M. Brown Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice J Clin Invest 120 2010 694 705
117. Z.L. Xiang, Z.C. Zeng, J. Fan, Z.Y. Tang, J. He, and H.Y. Zeng The expression of HIF-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome Mol Biol Rep 39 2012 2021 2029
118. K. Lee, H. Zhang, D.Z. Qian, S. Rey, J.O. Liu, and G.L. Semenza Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization Proc Natl Acad Sci U S A 106 2009 17910 17915
119. M. Jiao, and K.J. Nan Activation of PI3 kinase/Akt/HIF-1alpha pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma Int J Oncol 40 2012 461 468
120. A. Rapisarda, M. Hollingshead, B. Uranchimeg, C.A. Bonomi, S.D. Borgel, and J.P. Carter Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition Mol Cancer Ther 8 2009 1867 1877
121. A. Villanueva Rethinking future development of molecular therapies in hepatocellular carcinoma: a bottom-up approach J Hepatol 59 2013 392 395
122. I.B. Weinstein Cancer. Addiction to oncogenes - The Achilles heal of cancer Science 297 2002 63 64
123. J.C. Nault, A. De Reynies, A. Villanueva, J. Calderaro, S. Rebouissou, and G. Couchy A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection Gastroenterology 145 2013 176 187
124. Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.Y. Chiang, and A. Camargo Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
125. S. Roessler, H.L. Jia, A. Budhu, M. Forgues, Q.H. Ye, and J.S. Lee A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients Cancer Res 70 2010 10202 10212
126. H. van Malenstein, O. Gevaert, L. Libbrecht, A. Daemen, J. Allemeersch, and F. Nevens A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma Clin Cancer Res 16 2010 4278 4288
127. A. Villanueva, and J.M. Llovet Impact of intra-individual molecular heterogeneity in personalized treatment of hepatocellular carcinoma Hepatology 56 2012 2416 2419
128. E. Poon, A.L. Harris, and M. Ashcroft Targeting the hypoxia-inducible factor (HIF) pathway in cancer Expert Rev Mol Med 11 2009 e26
129. N.M. Chau, P. Rogers, W. Aherne, V. Carroll, I. Collins, and E. McDonald Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors Cancer Res 65 2005 4918 4928
130. D.A. Tennant, R.V. Duran, and E. Gottlieb Targeting metabolic transformation for cancer therapy Nat Rev Cancer 10 2010 267 277
131. L.M. Greenberger, I.D. Horak, D. Filpula, P. Sapra, M. Westergaard, and H.F. Frydenlund A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth Mol Cancer Ther 7 2008 3598 3608
132. D.A. Tennant, C. Frezza, E.D. MacKenzie, Q.D. Nguyen, L. Zheng, and M.A. Selak Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death Oncogene 28 2009 4009 4021
133. D.A. Tennant, and E. Gottlieb HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression J Mol Med 88 2010 839 849
134. Z.N. Rabbani, I. Spasojevic, X. Zhang, B.J. Moeller, S. Haberle, and J. Vasquez-Vivar Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor Free Radic Biol Med 47 2009 992 1004
135. J. Karar, G.J. Cerniglia, T. Lindsten, C. Koumenis, and A. Maity Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1alpha expression by blocking protein translation and increases cell death under hypoxia Cancer Biol Ther 13 2012 1102 1111
136. S. Darekar, K. Georgiou, M. Yurchenko, S.P. Yenamandra, G. Chachami, and G. Simos Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect PLoS One 7 2012 e42072
137. S. McFarlane, M.J. Nicholl, J.S. Sutherland, and C.M. Preston Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha Virology 414 2011 83 90